The Potential Role of PKC β in Diabetic Retinopathy and Macular Edema
Author:
- 1 December 2002
- journal article
- review article
- Published by Elsevier in Survey of Ophthalmology
- Vol. 47, S263-S269
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Effects of protein kinase Cβ inhibition on neurovascular dysfunction in diabetic rats: interaction with oxidative stress and essential fatty acid dysmetabolismDiabetes/Metabolism Research and Reviews, 2002
- Therapeutic potential of PKC inhibitors in painful diabetic neuropathyExpert Opinion on Investigational Drugs, 2001
- Blockade of Vascular Endothelial Cell Growth Factor Receptor Signaling Is Sufficient to Completely Prevent Retinal NeovascularizationThe American Journal of Pathology, 2000
- Treatment of Diabetic RetinopathyNew England Journal of Medicine, 1999
- Dramatic Inhibition of Retinal and Choroidal Neovascularization by Oral Administration of a Kinase InhibitorThe American Journal of Pathology, 1999
- Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth.Journal of Clinical Investigation, 1996
- Immunodeficiency in Protein Kinase Cβ-Deficient MiceScience, 1996
- Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β InhibitorScience, 1996
- (S)-13-[(Dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16,21-dimetheno- 1H,13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-dione (LY333531) and Related Analogues: Isozyme Selective Inhibitors of Protein Kinase CβJournal of Medicinal Chemistry, 1996
- Intracellular Signaling by Hydrolysis of Phospholipids and Activation of Protein Kinase CScience, 1992